Potential clinical impact of cardiovascular magnetic resonance assessment of ejection fraction on eligibility for cardioverter defibrillator implantation

Journal of Cardiovascular Magnetic Resonance

Volumn 14, Issue 1, 2012, Pages

  Joshi, Subodh B ^a   Connelly, Kim A ^a   Jimenez Juan, Laura ^b   Hansen, Mark ^c   Kirpalani, Anish ^a   Dorian, Paul ^a   Mangat, Iqwal ^a   Al Hesayen, Abdul ^a   Crean, Andrew M ^b   Wright, Graham A ^c   Yan, Andrew T ^a   Leong Poi, Howard ^a  

^a ST MICHAEL'S HOSPITAL   (Canada)

^b UNIVERSITY HEALTH NETWORK   (Canada)

^c SUNNYBROOK RESEARCH INSTITUTE   (Canada)

Author keywords

Cardiovascular Magnetic Resonance; Echocardiography; Ejection Fraction; Implantable cardioverter defibrillators

Indexed keywords

ADULT; AGED; ARTICLE; CARDIOVASCULAR MAGNETIC RESONANCE; CONTROLLED STUDY; ECHOCARDIOGRAPHY; FEMALE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART VENTRICLE THROMBOSIS; HUMAN; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; MAJOR CLINICAL STUDY; MALE; PATIENT ASSESSMENT; PRIORITY JOURNAL; TREATMENT RESPONSE;

AGED; DEATH, SUDDEN, CARDIAC; DEFIBRILLATORS, IMPLANTABLE; ECHOCARDIOGRAPHY; ELECTRIC COUNTERSHOCK; ELIGIBILITY DETERMINATION; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; OBSERVER VARIATION; ONTARIO; PATIENT SELECTION; PREDICTIVE VALUE OF TESTS; REPRODUCIBILITY OF RESULTS; STROKE VOLUME; THROMBOSIS; VENTRICULAR DYSFUNCTION, LEFT; VENTRICULAR FUNCTION, LEFT;

EID: 84867087809     PISSN: 10976647     EISSN: 1532429X     Source Type: Journal    
DOI: 10.1186/1532-429X-14-69     Document Type: Article

References (28)

1. ACC/AHA/ESC 2006 Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (writing committee to develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Zipes DP, Camm AJ, Borggrefe M, Buxton AE, Chaitman B, Fromer M, Gregoratos G, Klein G, Moss AJ, Myerburg RJ, et al. Circulation 2006 114 385 484 10.1161/CIRCULATIONAHA.106. 178233 16935995
2. ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices): developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons. Epstein AE, DiMarco JP, Ellenbogen KA, Estes NA 3rd, Freedman RA, Gettes LS, Gillinov AM, Gregoratos G, Hammill SC, Hayes DL, et al. Circulation 2008 117 350 408 18483207
3. Canadian Cardiovascular Society Consensus Conference guidelines on heart failure, update 2009: diagnosis and management of right-sided heart failure, myocarditis, device therapy and recent important clinical trials. Howlett JG, McKelvie RS, Arnold JM, Costigan J, Dorian P, Ducharme A, Estrella-Holder E, Ezekowitz JA, Giannetti N, Haddad H, et al. Can J Cardiol 2009 25 85 105 10.1016/S0828-282X(09)70477-5 19214293
4. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. Moss AJ, Zareba W, Hall WJ, Klein H, Wilber DJ, Cannom DS, Daubert JP, Higgins SL, Brown MW, Andrews ML, N Engl J Med 2002 346 877 883 10.1056/NEJMoa013474 11907286 (Pubitemid 34984635)
5. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. Bardy GH, Lee KL, Mark DB, Poole JE, Packer DL, Boineau R, Domanski M, Troutman C, Anderson J, Johnson G, et al. N Engl J Med 2005 352 225 237 10.1056/NEJMoa043399 15659722 (Pubitemid 40110811)
6. Prophylactic use of an implantable cardioverter-defibrillator after acute myocardial infarction. Hohnloser SH, Kuck KH, Dorian P, Roberts RS, Hampton JR, Hatala R, Fain E, Gent M, Connolly SJ, N Engl J Med 2004 351 2481 2488 10.1056/NEJMoa041489 15590950 (Pubitemid 39603155)
7. Comparison of interstudy reproducibility of cardiovascular magnetic resonance with two-dimensional echocardiography in normal subjects and in patients with heart failure or left ventricular hypertrophy. Grothues F, Smith GC, Moon JC, Bellenger NG, Collins P, Klein HU, Pennell DJ, Am J Cardiol 2002 90 29 34 10.1016/S0002-9149(02)02381-0 12088775 (Pubitemid 34671198)
8. Assessment of systolic left ventricular function: a multi-centre comparison of cineventriculography, cardiac magnetic resonance imaging, unenhanced and contrast-enhanced echocardiography. Hoffmann R, von Bardeleben S, ten Cate F, Borges AC, Kasprzak J, Firschke C, Lafitte S, Al-Saadi N, Kuntz-Hehner S, Engelhardt M, et al. Eur Heart J 2005 26 607 616 15618026 (Pubitemid 40461103)
9. Comparison of left ventricular ejection fraction and volumes in heart failure by echocardiography, radionuclide ventriculography and cardiovascular magnetic resonance; are they interchangeable? Bellenger NG, Burgess MI, Ray SG, Lahiri A, Coats AJ, Cleland JG, Pennell DJ, Eur Heart J 2000 21 1387 1396 10.1053/euhj.2000.2011 10952828 (Pubitemid 30599134)
10. Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, Picard MH, Roman MJ, Seward J, Shanewise JS, et al. J Am Soc Echocardiogr 2005 18 1440 1463 10.1016/j.echo.2005.10.005 16376782 (Pubitemid 41821197)
11. Multicontrast late gadolinium enhancement imaging enables viability and wall motion assessment in a single acquisition with reduced scan times. Connelly KA, Detsky JS, Graham JJ, Paul G, Vijayaragavan R, Dick AJ, Wright GA, J Magn Reson Imaging 2009 30 771 777 10.1002/jmri.21907 19787723
12. Visualization of ventricular thrombi with contrast-enhanced magnetic resonance imaging in patients with ischemic heart disease. Mollet NR, Dymarkowski S, Volders W, Wathiong J, Herbots L, Rademakers FE, Bogaert J, Circulation 2002 106 2873 2876 10.1161/01.CIR.0000044389.51236.91 12460863 (Pubitemid 35424733)
13. Clinical, imaging, and pathological characteristics of left ventricular thrombus: a comparison of contrast-enhanced magnetic resonance imaging, transthoracic echocardiography, and transesophageal echocardiography with surgical or pathological validation. Srichai MB, Junor C, Rodriguez LL, Stillman AE, Grimm RA, Lieber ML, Weaver JA, Smedira NG, White RD, Am Heart J 2006 152 75 84 10.1016/j.ahj.2005.08.021 16824834 (Pubitemid 43974727)
14. Contrast-enhanced anatomic imaging as compared to contrast-enhanced tissue characterization for detection of left ventricular thrombus. Weinsaft JW, Kim RJ, Ross M, Krauser D, Manoushagian S, LaBounty TM, Cham MD, Min JK, Healy K, Wang Y, et al. JACC Cardiovasc Imaging 2009 2 969 979 10.1016/j.jcmg.2009.03. 017 19679285
15. External loop recorders: determinants of diagnostic yield in patients with syncope. Gula LJ, Krahn AD, Massel D, Skanes A, Yee R, Klein GJ, Am Heart J 2004 147 644 648 10.1016/j.ahj.2003.10.036 15077079 (Pubitemid 38900449)
16. Cost of preimplantation cardiac imaging in patients referred for a primary-prevention implantable cardioverter-defibrillator. Krahn AD, Hoch JS, Rockx MA, Leong-Sit P, Gula LJ, Yee R, Skanes AC, Klein GJ, Am J Cardiol 2008 102 588 592 10.1016/j.amjcard.2008.04.067 18721517
17. Limitations in the current screening practice of assessing left ventricular ejection fraction for a primary prophylactic implantable defibrillator in southern Ontario. Lane C, Dorian P, Ghosh N, Radina M, O'Donnell S, Thorpe K, Mangat I, Korley V, Pinter A, Can J Cardiol 2010 26 118 124
18. Outcomes in heart failure patients referred for consideration of implantable cardioverter defibrillator for primary prophylaxis of sudden cardiac death: what are the risks of waiting? Ghosh N, Mangat I, O'Donnell SS, Pinter A, Korley V, Lane C, Dorian P, Can J Cardiol 2009 25 342 346 10.1016/S0828-282X(09)70719-6 19812807
19. Ejection fraction assessment and survival: an analysis of the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT). Gula LJ, Klein GJ, Hellkamp AS, Massel D, Krahn AD, Skanes AC, Yee R, Anderson J, Johnson GW, Poole JE, et al. Am Heart J 2008 156 1196 1200 10.1016/j.ahj.2008.08.007 19033019
20. Electrocardiogram-gated single-photon emission computed tomography versus cardiac magnetic resonance imaging for the assessment of left ventricular volumes and ejection fraction: a meta-analysis. Ioannidis JP, Trikalinos TA, Danias PG, J Am Coll Cardiol 2002 39 2059 2068 10.1016/S0735-1097(02)01882-X 12084609 (Pubitemid 34628291)
21. Accurate and reproducible measurement of left ventricular volume and ejection fraction by contrast echocardiography: a comparison with magnetic resonance imaging. Malm S, Frigstad S, Sagberg E, Larsson H, Skjaerpe T, J Am Coll Cardiol 2004 44 1030 1035 10.1016/j.jacc.2004.05.068 15337215 (Pubitemid 39165138)
22. Administration of an intravenous perfluorocarbon contrast agent improves echocardiographic determination of left ventricular volumes and ejection fraction: comparison with cine magnetic resonance imaging. Hundley WG, Kizilbash AM, Afridi I, Franco F, Peshock RM, Grayburn PA, J Am Coll Cardiol 1998 32 1426 1432 10.1016/S0735-1097(98)00409-4 9809958 (Pubitemid 28522405)
23. Impact of papillary muscles in ventricular volume and ejection fraction assessment by cardiovascular magnetic resonance. Sievers B, Kirchberg S, Bakan A, Franken U, Trappe HJ, J Cardiovasc Magn Reson 2004 6 9 16 15054924 (Pubitemid 38316423)
24. Left ventricular papillary muscles and trabeculae are significant determinants of cardiac MRI volumetric measurements: effects on clinical standards in patients with advanced systolic dysfunction. Weinsaft JW, Cham MD, Janik M, Min JK, Henschke CI, Yankelevitz DF, Devereux RB, Int J Cardiol 2008 126 359 365 10.1016/j.ijcard.2007.04.179 17698216 (Pubitemid 351636363)
25. Low incidence of stroke in ambulatory patients with heart failure: a prospective study. Katz SD, Marantz PR, Biasucci L, Jondeau G, Lee K, Brennan C, LeJemtel TH, Am Heart J 1993 126 141 146 10.1016/S0002-8703(07)80021-4 8322656 (Pubitemid 23201585)
26. The dilemma of ICD implant testing. Swerdlow CD, Russo AM, Degroot PJ, Pacing Clin Electrophysiol 2007 30 675 700 10.1111/j.1540-8159.2007.00730.x 17461879 (Pubitemid 46656108)
27. Comparison of contrast agent-enhanced versus non-contrast agent-enhanced real-time three-dimensional echocardiography for analysis of left ventricular systolic function. Krenning BJ, Kirschbaum SW, Soliman OI, Nemes A, van Geuns RJ, Vletter WB, Veltman CE, Ten Cate FJ, Roelandt JR, Geleijnse ML, Am J Cardiol 2007 100 1485 1489 10.1016/j.amjcard.2007.06.042 17950813 (Pubitemid 47576031)
28. Left ventricular volume measurement with echocardiography: a comparison of left ventricular opacification, three-dimensional echocardiography, or both with magnetic resonance imaging. Jenkins C, Moir S, Chan J, Rakhit D, Haluska B, Marwick TH, Eur Heart J 2009 30 98 106 18997179